Biotech researchers are making strides in areas from living neural networks to novel cancer vaccines, but regulatory ...
Recent FDA approvals, including Glaukos’ incision-free Epioxa therapy for keratoconus, signal a shift toward less invasive, more durable corneal treatments. Alongside regenerative medicine ...
Press release - No. 9 / 2026 The Zealand Pharma Board of Directors proposes to elect Camilla Sylvest to the Board of ...
Company secures $5M in funding to accelerate its rapid testing platformUSP Validation achieved, reinforcing 20-hour testing methodFaster test results replace the standard 14-day USP sterility test SAN ...
Outreach initiative supports awareness of agitation and patient engagement as enrollment approaches completion POTOMAC, MD / ACCESS Newswire / April 28, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("I ...
PBM reform championed by Sen. Warner is a necessary step to lower health care costs for patients, VA Bio’s John Newby writes ...
Earlier today, Nautilus Biotechnology released financial results for the quarter ended March 31, 2026. If you haven't received this news release or if you'd like to be added to the company's ...
Pitt Street Research and Euroz Hartleys have released research notes on Dimerix highlighting upside potential as progresses ...
HERVolution Therapeutics, a biotechnology company pioneering human endogenous retrovirus (HERV)-targeting immunotherapies for oncology, metabolic diseases, and longevity, today announced the ...
Building on landmark Nature Biotechnology findings, Nutromics secures AU$3 million in a AU$11.2 million consortium to ...
Plants produce an extraordinary array of phytochemicals that are essential for their survival, ecological interactions, and ...
There has been a swing towards in vivo CAR-T therapies lately, as big pharmas sign acquisition deals and new therapies hit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results